2023 Performance Snapshot of Home Health and Hospice Leaders
Explore the financial performance of key players in the Home Health and Hospice (HH&H) sector during 2023. From Amedisys’ steady growth to Addus’ fluctuations, discover the ups and downs, strategic moves and investor interest that defined the industry. 2023 Quarterly Stock Performance of Publicly Traded HH&H Companies: CompanyQ1 2023Q2 2023Q3 2023Q4 2023Amedisys$73.55 $91.44 $93.40 $95.06 Encompass Health$54.10 $67.71 $67.16 $66.72 The Pennant Group$14.28 $12.28 $11.13 $13.92 Addus HomeCare$106.76 $92.70 $85.19 $92.85 Enhabit$13.91 $11.50 $11.25 $10.35 Aveanna... Read More »
Addus HomeCare Reports Impressive Q2:23 Earnings Led by Personal Care, Eyes Expansion Amidst Segment Challenges
Addus HomeCare (NASDAQ: ADUS) came out with its second quarter financial results on July 31, 2023, holding its earnings call the next morning. Addus posted revenue of $260 million during Q2:23, an increase of 9.7% over Q2:22 when it generated revenue of $237 million. The company also reported second-quarter net income of $14.9 million, an increase of 32% compared to the $11.3 million reported during the same period last year. Last quarter, it was expected that Addus would post earnings of $0.90 per share when it actually produced earnings of $0.97, delivering a surprise increase of 7.78%. This marks the fourth consecutive quarter in which the company has exceeded EPS estimates. Addus’... Read More »
Addus HomeCare Expands in New Mexico
Addus HomeCare Corporation announced last week the $29 million acquisition of Armada Skilled Home Health & Hospice in New Mexico. Armada currently serves an average daily census of approximately 1,100 patients for home health services and 100 patients for hospice care, with primary coverage across Bernalillo County and surrounding counties. It has $23 million in annualized revenue. This deal expands Addus’ presence in New Mexico, an important market for the company. It is yet another step toward the company’s mission to expand its home health, hospice, and personal care lines in specific regions and states, as it did in Ohio in November when it bought Queen City Hospice for... Read More »
Home Health & Hospice Sector Deals Dipped in Q3:19
Deal volume in the home health and hospice sector dipped slightly in the third quarter of 2019, down 23% with 20 publicly announced transactions, compared with 26 acquisitions in the second quarter, according to data from HealthCareMandA.com. Compared with the third quarter of 2018, home health and hospice M&A activity decreased by 20%, when 25 acquisitions were announced. Six of the transactions disclosed prices in the third quarter of 2019, for a combined total of nearly $1.2 billion. In the same quarter of 2018, the total dollar value based on disclosed prices was just $7.2 million. Of the 20 transactions announced in the third quarter, 35% were announced by private equity firms or... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
